Pfizer seeks emergency authorization for COVID-19 booster in children ages 5 to 11

Pfizer-BioNTech submitted an application to the U.S. Food and Drug Administration Tuesday, seeking emergency approval for children ages 5 to 11 to receive COVID-19 vaccine boosters.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.